Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25073615 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ekaterina Bezverkhniaia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden. Hauptthemen laut MEDLINE: Technetium, Fabaceae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Research Council.
Abstract (Originalsprache)
Previously, we designed the EuK-based PSMA ligand BQ0413 with an maE3 chelator for labeling with technetium-99m. It showed efficient tumor targeting, but our preclinical data and preliminary clinical results indicated that the renal excretion levels need to be decreased. We hypothesized that this could be achieved by a decrease in the ligand’s total negative charge, achieved by substituting negatively charged glutamate residues in the chelator with glycine. The purpose of this study was to evaluate the tumor targeting and biodistribution of two new PSMA inhibitors, BQ0411 and BQ0412, compared to BQ0413. Conjugates were radiolabeled with Tc-99m and characterized in vitro, using PC3-pip cells, and in vivo, using NMRI and PC3-pip tumor-bearing mice. [99mTc]Tc-BQ0411 and [99mTc]Tc-BQ0412 demonstrated PSMA-specific binding to PC3-pip cells with picomolar affinity. The biodistribution pattern for the new conjugates was characterized by rapid excretion. The tumor uptake for [99mTc]Tc-BQ0411 was 1.6-fold higher compared to [99mTc]Tc-BQ0412 and [99mTc]Tc-BQ0413. [99mTc]Tc-BQ0413 has demonstrated predominantly renal excretion, while the new conjugates underwent both renal and hepatobiliary excretion. In this study, we have demonstrated that in such small targeting ligands as PSMA-binding EuK-based pseudopeptides, the structural blocks that do not participate in binding could have a crucial role in tumor targeting and biodistribution. The presence of a glycine-based coupling linker in BQ0411 and BQ0413 seems to optimize biodistribution. In conclusion, the substitution of amino acids in the chelating sequence is a promising method to alter the biodistribution of [99mTc]Tc-labeled small-molecule PSMA inhibitors. Further improvement of the biodistribution properties of BQ0413 is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden.
- Department of Immunology, Genetics and Pathology, Uppsala University, 752 37 Uppsala, Sweden.
- Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.
ORCID-Profile: Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova
Förderung
- Swedish Cancer Society
- Swedish Research Council
Zitieren
APA
Bezverkhniaia, E., Kanellopoulos, P., Rosenström, U., Tolmachev, V., & Orlova, A. (2024). Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073615
Vancouver
Bezverkhniaia E, Kanellopoulos P, Rosenström U, Tolmachev V, Orlova A. Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073615
BibTeX
@article{Bezverkhniaia2024,
author = {Bezverkhniaia, Ekaterina and Kanellopoulos, Panagiotis and Rosenström, Ulrika and Tolmachev, Vladimir and Orlova, Anna},
title = {Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25073615}
}
EUVIMED